TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT03145194

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03145194
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03145194. Randomized; triple masking; primary purpose treatment. Start 2017-01-30 (actual); primary completion 2018-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Ticagrelor
Intervention (Other)
Placebo
Lead sponsor
Papworth Hospital NHS Foundation Trust (class: other government)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct03145194
Content hash
a0bbea5717a0584bbe2fe3664600d90123713a4833ef1c630cac70885388e891